Kim Krogsgaard

4.8k total citations · 1 hit paper
88 papers, 3.6k citations indexed

About

Kim Krogsgaard is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Kim Krogsgaard has authored 88 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 49 papers in Hepatology and 12 papers in Infectious Diseases. Recurrent topics in Kim Krogsgaard's work include Hepatitis B Virus Studies (43 papers), Hepatitis C virus research (43 papers) and Liver Disease Diagnosis and Treatment (31 papers). Kim Krogsgaard is often cited by papers focused on Hepatitis B Virus Studies (43 papers), Hepatitis C virus research (43 papers) and Liver Disease Diagnosis and Treatment (31 papers). Kim Krogsgaard collaborates with scholars based in Denmark, Sweden and United States. Kim Krogsgaard's co-authors include Christian Gluud, Per Hölmich, Jan Aldershvile, P. Wantzin, Peter Kryger, A M Bjerg, Jens Nielsen, Poul Andersson, Michael Bachmann Nielsen and Inge‐Lis Kanstrup and has published in prestigious journals such as The Lancet, PLoS ONE and Hepatology.

In The Last Decade

Kim Krogsgaard

87 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

2015 379 citations Ole S. Søgaard, Steffen Leth et al. PLoS Pathogens profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Kim Krogsgaard	1.9k	1.6k	755	679	507	88	3.6k
Dominique Salmon	2.0k 1.1×	645 0.4×	1.8k 2.4×	779 1.1×	663 1.3×	147	4.7k
Matthias Stoll	1.1k 0.6×	551 0.3×	1.3k 1.8×	930 1.4×	221 0.4×	104	3.2k
Patrice Massip	1.0k 0.5×	161 0.1×	2.5k 3.3×	2.3k 3.3×	228 0.4×	127	4.0k
D. Neau	1.2k 0.6×	708 0.4×	1.7k 2.2×	1.2k 1.7×	156 0.3×	152	3.2k
Christoph Boesecke	1.5k 0.8×	1.1k 0.7×	1.4k 1.8×	679 1.0×	157 0.3×	141	2.8k
Nina Weis	1.6k 0.9×	1.3k 0.8×	663 0.9×	170 0.3×	143 0.3×	181	3.0k
Ralph DeMasi	752 0.4×	520 0.3×	2.6k 3.4×	2.3k 3.4×	256 0.5×	82	3.7k
Fehmida Visnegarwala	1.2k 0.6×	77 0.0×	1.5k 2.0×	680 1.0×	624 1.2×	30	2.7k
E. McKinnon	717 0.4×	97 0.1×	1.3k 1.8×	1.1k 1.7×	263 0.5×	90	2.9k
Brygida Knysz	787 0.4×	384 0.2×	1.2k 1.6×	707 1.0×	125 0.2×	105	2.2k

Countries citing papers authored by Kim Krogsgaard

Since Specialization

Citations

This map shows the geographic impact of Kim Krogsgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Krogsgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Krogsgaard more than expected).

Fields of papers citing papers by Kim Krogsgaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Krogsgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Krogsgaard. The network helps show where Kim Krogsgaard may publish in the future.

Co-authorship network of co-authors of Kim Krogsgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Krogsgaard. A scholar is included among the top collaborators of Kim Krogsgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Krogsgaard. Kim Krogsgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tapia, Gonzalo, Jesper Falkesgaard Højen, Mats Ökvist, et al.. (2017). Sequential Vacc-4x and romidepsin during combination antiretroviral therapy (cART): Immune responses to Vacc-4x regions on p24 and changes in HIV reservoirs. Journal of Infection. 75(6). 555–571. 26 indexed citations

Leth, Steffen, Mariane Høgsbjerg Schleimann, Sara Konstantin Nissen, et al.. (2016). Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial. The Lancet HIV. 3(10). e463–e472. 128 indexed citations

Søgaard, Ole S., Steffen Leth, Rikke Olesen, et al.. (2015). The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo. PLoS Pathogens. 11(9). e1005142–e1005142. 379 indexed citations breakdown →

Kirk, Vibeke, M. Bay, Jan Parner, et al.. (2004). N-Terminal proBNP and Mortality in Hospitalised Patients with Heart Failure and Preserved Vs. Reduced Systolic Function: Data from the Prospective Copenhagen Hospital Heart Failure Study (CHHF). European Journal of Heart Failure. 6(3). 335–341. 83 indexed citations

Diness, Birgitte Rode, et al.. (2003). Chlamydia pneumoniae antibodies and endothelial function as assessed by flow-mediated dilation in patients with chest pain with and without ischemic heart disease. The American Journal of Cardiology. 91(8). 982–985. 2 indexed citations

Jensen, Lise Heilmann, Carsten Heilmann, Else Smith, et al.. (2003). Efficacy of Selective Antenatal Screening for Hepatitis B Among Pregnant Women in Denmark: Is Selective Screening Still an Acceptable Strategy in a Low-endemicity Country?. Scandinavian Journal of Infectious Diseases. 35(6-7). 378–382. 17 indexed citations

Krogsgaard, Kim, et al.. (2002). Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B. The Cochrane Database of Systematic Reviews. CD000345–CD000345. 7 indexed citations

Hannoun, Charles, et al.. (2001). Mutations in the X region and core promoter are rare and have little impact on response to interferon therapy for chronic hepatitis B. Journal of Medical Virology. 66(2). 171–178. 10 indexed citations

Eugen‐Olsen, Jesper, et al.. (2000). Prevalence and Prognostic Significance of Infection with TT Virus in Patients Infected with Human Immunodeficiency Virus. The Journal of Infectious Diseases. 181(5). 1796–1799. 90 indexed citations

10.

Krogsgaard, Kim, et al.. (1999). [Occurrence of hepatitis B and C among mentally retarded].. PubMed. 161(31). 4393–6. 6 indexed citations

11.

Krogsgaard, Kim, Patrick Marcellin, C. Trépo, et al.. (1998). [Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B].. PubMed. 160(39). 5657–61. 2 indexed citations

12.

Krogsgaard, Kim, et al.. (1998). The long‐term effect of treatment with interferon‐α2a in chronic hepatitis B. Journal of Viral Hepatitis. 5(6). 389–397. 65 indexed citations

13.

Gluud, Christian & Kim Krogsgaard. (1997). Would you trust a surrogate respondent?. The Lancet. 349(9053). 665–666. 6 indexed citations

14.

Krogsgaard, Kim, Niels Bindslev, Erik Christensen, et al.. (1994). The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. Journal of Hepatology. 21(4). 646–655. 70 indexed citations

15.

Blomberg, Jonas, Torkil Moestrup, B. G. Hansson, et al.. (1994). HTLV-I and -II in Intravenous Drug Users from Sweden and Denmark. Scandinavian Journal of Infectious Diseases. 26(1). 23–26. 13 indexed citations

16.

Knudsen, F, P. Wantzin, Knud Rasmussen, et al.. (1993). Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney International. 43(6). 1353–1356. 81 indexed citations

17.

Krogsgaard, Kim, P. Wantzin, L Mathiesen, & Helmer Ring‐Larsen. (1991). Chronic Evolution of Acute Hepatitis B: The Significance of Simultaneous Infections with Hepatitis C and D. Scandinavian Journal of Gastroenterology. 26(3). 275–280. 18 indexed citations

18.

Melbye, Mads, Robert J. Biggar, P. Wantzin, et al.. (1990). Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men.. BMJ. 301(6745). 210–212. 124 indexed citations

19.

Krogsgaard, Kim, et al.. (1990). Reactivation of viral replication in anti‐HBe positive chronic HBsAg carriers. Liver International. 10(1). 54–58. 9 indexed citations

20.

Hegedüs, László, Nini Rasmussen, Vibeke Ravn, et al.. (1988). Independent effects of liver disease and chronic alcoholism on thyroid function and size: The possibility of a toxic effect of alcohol on the thyroid gland. Metabolism. 37(3). 229–233. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact